Caribou Biosciences, Inc. - Common Stock (CRBU)

CUSIP: 142038108

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Shares outstanding
92,189,700
Total 13F shares
70,779,287
Share change
+27,507,847
Total reported value
$338,477,161
Put/Call ratio
80%
Price per share
$4.78
Number of holders
126
Value change
+$132,380,976
Number of buys
83
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 142038108?
CUSIP 142038108 identifies CRBU - Caribou Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q3 2023

As of 30 Sep 2023, Caribou Biosciences, Inc. - Common Stock (CRBU) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 70,779,287 shares. The largest 10 holders included PFM Health Sciences, LP, BlackRock Inc., Avidity Partners Management LP, STATE STREET CORP, VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Point72 Asset Management, L.P., Paradigm Biocapital Advisors LP, Rokos Capital Management LLP, and Assenagon Asset Management S.A.. This page lists 126 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.